Buy Quanta Pharma MT2 – The Ped Pharma

Quanta Pharma MT2 Specifications

Research Benefits

• ✓Melanogenesis stimulation – Activates MC1R receptors to promote melanin synthesis in melanocytes
• ✓Photoprotection research – Investigated for potential protective effects against UV-induced DNA damage
• ✓Melanocortin pathway studies – Useful for researching MC1R, MC3R, MC4R, and MC5R receptor interactions
• ✓Appetite regulation – MC4R activation is linked to satiety signalling pathways
• ✓High stability – Lyophilised format ensures extended shelf life when stored correctly

How Quanta Pharma MT2 Works

Quanta Pharma MT2 is a cyclic heptapeptide analogue of the naturally occurring alpha-melanocyte stimulating hormone (α-MSH). It binds to melanocortin receptors, primarily MC1R, which are found on melanocytes in the skin. This binding triggers a cascade that increases the production of eumelanin, the brown-black pigment responsible for skin colour.

Unlike natural α-MSH which has a very short half-life, Quanta Pharma MT2 has been structurally modified to resist enzymatic degradation, giving it a much longer duration of action. This makes it particularly useful for research applications requiring sustained receptor activation.

Quanta Pharma MT2 vs Melanotan 1

Melanotan 1 (afamelanotide) is a linear peptide with higher selectivity for MC1R receptors. Quanta Pharma MT2 is a cyclic peptide with broader receptor affinity, activating MC1R, MC3R, MC4R, and MC5R. This broader activity profile makes MT2 more versatile for research into the full melanocortin system, though it also means effects beyond pigmentation may be observed in studies.

Why Choose Quanta Pharma MT2?

Quanta Pharma produces pharmaceutical-grade peptides with verified 99% purity and accurate dosing. Each vial of Quanta Pharma MT2 contains a full 10mg of lyophilised peptide, manufactured under strict quality control. The convenient 10mg dosage provides excellent value for extended research protocols.